Review and cost-effective and rapid tuberculosis screening: Implementing the sputum pooling method in Indonesia
Article Sidebar
Main Article Content
Abstract
Background: Indonesia continues to face significant challenges in meeting its tuberculosis (TB) case detection targets, partly due to the underutilization of diagnostic resources like Rapid Molecular Tests (RMTs). Innovative, costeffective strategies are urgently needed to scale up screening efforts.
Objectives: This study aims to review the diagnostic accuracy, cost-effectiveness, and implementation considerations of the pooling sputum strategy to assess its potential for enhancing TB screening in Indonesia.
Materials and methods: This study was conducted using publicly available data from the Indonesian Ministry of Health and findings from existing literature. The projected impact was analyzed by implementing a 4-sample pooling sputum method for RMT (Xpert MTB/RIF Ultra) compared to the current individual testing strategy.
Results: The analysis projects that the pooling sputum strategy could increase RMT screening capacity fourfold. The national average monthly tests per RMT unit could rise from 120 to 480 individuals screened. Consequently, the projected time required to screen 100,000 individuals per province could decrease from an average of 5.5 months to 1.4 months. The strategy offers potential cost savings averaging 36.71% (±14.97%). A review of diagnostic data from previous studies shows high accuracy (sensitivity 97.35%; specificity 99.25%).
Conclusion: The pooling sputum method presents a viable and powerful strategy to significantly enhance the efficiency of TB screening in Indonesia. This approach can substantially increase RMT utilization, accelerate case detection, and reduce costs, thereby helping Indonesia progress towards its 2030 TB elimination targets. A pilot study is recommended to validate these findings within the Indonesian healthcare context.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Personal views expressed by the contributors in their articles are not necessarily those of the Journal of Associated Medical Sciences, Faculty of Associated Medical Sciences, Chiang Mai University.
References
Indonesian Government, Ministry of Health. Tuberculosis control program report. 2022 Available from: https://tbindonesia.or.id/wp-content/uploads/2023/09/Laporan-Tahunan-Program-TBC-2022.pdf.
Indonesian Government, Ministry of Health. Through the 4th INA - TIME 2022 Activity, Minister of Health Budi requests 90% of TB patients can be detected in 2030. 2023 Available from: http://p2p.kemkes.go.id/melalui-ina-time2022-ke-4-menkesbudi-minta-90-penderitatbc-dapat-terdeteksi-ditahun-2024.
Indonesian Government, Ministry of Health. Technical manual for tuberculosis testing using GeneXpert molecular rapid test. 2023 Available from: https://tbindonesia.or.id/wp-content/uploads/2024/02/Buku-Petunjuk-Teknis-Pemeriksaan- TBCMenggunakan-Alat-RMT-GeneXpert_2023.pdf.
Ahmed N, Hasnain SE. Molecular epidemiology of tuberculosis in India: Moving forward with a systems biology approach. Tuberculosis. 2011; 91(5): 407-13. doi: 10.1016/j.tube.2011.03.006.
McCreesh N, White RG. An explanation for the low proportion of tuberculosis that results from transmission between household and known social contacts. Sci Rep. 2018; 8: 5382. doi: 10.1038/s41598-018-23797-2.
World Health Organization. Tb reaches the 3 million find treat cure TB. 2014. Available from: http://www.stoptb.org/assets/documents/resources/publications/acsm/WORLD_TB_DAY_BROCHURE_14March.pdf.
Indonesian Government, The House of Representatives. DPR members appreciate increased budget for TB control. 2021. Available from: https://www.dpr.go.id/berita/detail/id/29969/t/Anggota+DPR+Appreciates+Increased+Budget+for+TB+Control.
The Conversation. Indonesia needs to triple funding to control tuberculosis - Here’s a start. 2023. Available from: https://theconversation.com/indonesiaperlu-tingkatkan-pendanaan-tiga-kali-lipat-untukkendalikan-tuberkulosis-inilah-awal-yang-harusdilakukan-216266.
Cuevas LE, Santos VS, Almeida LSVM, et al. Systematic review of pooling sputum as an efficient method for Xpert MTB/RIF tuberculosis testing during the COVID-19 pandemic. Emerg Infect Dis. 2021; 27(3): 1-9. doi: 10.3201/eid2703.204090.
Santos VS, Allgayer MF, Kontogianni K, Rocha JE, et al. Pooling of sputum samples to increase tuberculosis diagnostic capacity in Brazil during the COVID-19 pandemic. Int J Infect Dis. 2023; 129: 10-4. doi: 10.1016/j.ijid.2023.01.009.
Zishiri V, Chihota V, McCarthy K, Charalambous S, Churchyard GJ, Hoffmann CJ. Pooling sputum from multiple individuals for Xpert® MTB/ RIF testing: A strategy for screening high-risk populations. Int J Tuberc Lung Dis. 2015; 19(1): 87-90. doi: 10.5588/ijtld.14.0372.
Dos Santos PC P, da Silva Santos A, de Oliveira RD, et al. Pooling sputum samples for efficient mass tuberculosis screening in prisons. Clin Infect Dis. 2022; 74(12): 2115-21. doi: 10.1093/cid/ciab847.
Iem V, Chittamany P, Suthepmany S , et al. Pooled testing of sputum with Xpert MTB/RIF and Xpert Ultra during tuberculosis active case finding campaigns in Lao People’s Democratic Republic. BMJ Global Health. 2022; 7(2): e007592. doi: 10.1136/bmjgh-2021-007592.
Phuong NTB, Anh NT, Van SN, et al. Effect of two alternative methods of pooling sputum prior to testing for tuberculosis with Genexpert MTB/RIF. BMC Infect Dis. 2019; 19: 347. doi: 10.1186/s12879-019-3778-9.
Zeng J, Huang H, Liu X. et al. Pooling sputum samples for the Xpert MTB/RIF assay: A practical screening strategy for highly infectious tuberculosis cases. BMC Infect Dis. 2024; 24: 122. doi: 10.1186/s12879-024-09020-w.
World Health Organization. Antigen-detection in the diagnosis of SARS-CoV-2 infection: Emergencies preparedness, WHO Headquarters (HQ). 2021. Available from: https://www.who.int/publications/i/item/antigen-detection-in-thediagnosis-of-sars-cov-2infection-using-rapidimmunoassays.
Iem V, Bimba JS, Santos VS. et al. Pooling sputum testing to diagnose tuberculosis using Xpert MTB/RIF and Xpert Ultra: A cost-effectiveness analysis. BMC Infect Dis. 2023; 23: 341. doi: 10.1186/s12879-023-08330-9.
Abdurrahman ST, Mbanaso O, Lawson L, et al. Testing pooled sputum with Xpert MTB/RIF for diagnosis of pulmonary tuberculosis to increase affordability in low-income countries. J Clin Microbiol. 2015; 53(8): 2502-8. doi: 10.1128/JCM.00864-15.
Vuchas C, Teyim P, Dang BF, et al. Implementation of large-scale pooled testing to increase rapid molecular diagnostic test coverage for tuberculosis: a retrospective evaluation. Sci Rep. 2023; 13(1): 15358. doi: 10.1038/s41598-023-41904-w.
Chry M, Smelyanskaya M, Ky M, et al. Can the high sensitivity of Xpert MTB/RIF Ultra be harnessed to save cartridge costs? Results from a pooled sputum evaluation in Cambodia. Trop Med Infect. 2020; 5 : 27. doi: 10.3390/tropicalmed5010027.
Ma Z, Zhang L, Li S, et al. Pooled sputum testing by Xpert® MTB/RIF Ultra for active tuberculosis case finding among high-risk groups in a low-incidence area: A prospective study. Infect Dis. 2024; 56 (6): 434-40. doi: 10.1080/23744235.2024.2320324.
Sorsa A, Kaso M. Diagnostic performance of GeneXpert in tuberculosis-HIV Co-infected patients at Asella Teaching and Referral Hospital, Southeastern Ethiopia: A cross sectional study. PLoS ONE. 2021; 16(1): e0242205. doi: 10.1371/journal.pone.0242205.
World Health Organization. Global tuberculosis report 2021. 2022. Available from: https://www.who.int/publications/i/item/9789240037021.
World Health Organization. Tuberculosis key facts. 2022. Available from: https://www.who.int/indonesia/news/campaign/tb-day-2022/factsheets.
Abdurrahman ST, Mbanaso O, Lawson L, et al. Testing Pooled Sputum with Xpert MTB/RIF for diagnosis of pulmonary tuberculosis to increase affordability in low-income countries. J Clin JCM.00864-15.
Vuchas C, Teyim P, Dang BF, et al. Implementation of large-scale pooled testing to increase rapid molecular diagnostic test coverage for tuberculosis: a retrospective evaluation. Sci Rep. 2023; 13(1): 15358. doi: 10.1038/s41598-023-41904-w.
Chry M, Smelyanskaya M, Ky M, et al. Can the High Sensitivity of Xpert MTB/RIF Ultra Be Harnessed to save cartridge costs? Results from a pooled sputum evaluation in Cambodia. Trop Med Infect. 2020; 5: 27. doi: 10.3390/tropicalmed5010027
Ma Z, Zhang L, Li S, , et al. Pooled sputum testing by Xpert® MTB/RIF Ultra for active tuberculosis case finding among high-risk groups in a low-incidence area: A prospective study. Infect Dis. 2024; 56 (6): 434-440. doi: 10.1080/23744235.2024.2320324.
Sorsa A, Kaso M. Diagnostic performance of GeneXpert in tuberculosis-HIV co-infected patients at Asella Teaching and Referral Hospital, Southeastern Ethiopia: A cross sectional study. PLoS ONE. 2021; 16(1): e0242205. doi: 10.1371/journal.pone.0242205.
World Health Organization. Global tuberculosis report 2021. 2022. Available from: https://www.who.int/publications/i/item/9789240037021.
World Health Organization. Tuberculosis key facts. 2022. Available from: https://www.who.int/indonesia/news/campaign/tb-day-2022/factsheets.
